Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.
| Image |  |
|---|---|
| Description | scientific article published on 17 October 2017 |
| Author/s |
author: Xavier Carbonell-Estrany Manuel Sánchez Luna Itziar Oyagüez Federico Martinón-Torres |
| Publication date | October 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |